Literature DB >> 228053

Guanidine-sensitive Na+ accumulation by poliovirus-infected HeLa cells.

C N Nair, J W Stowers, B Singfield.   

Abstract

The Na+ content of poliovirus-infected HeLa S3 cells increased during the late phase of virus replication, after virus inhibition of host cell protein synthesis and in coincidence with late viral functions. Guanidine hydrochloride blocked the rise in Na+ content, whereas the antiguanidine agent choline fully reversed the guanidine block. Expression of one or more late viral functions was essential for Na+ accumulation to occur because accumulation was inhibited by cycloheximide or guanidine added to the infected culture during the late phase. Increased adenosine triphosphatase activity appears to be primarily responsible for Na+ accumulation by virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228053      PMCID: PMC353434     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A CYTOPLASMIC STRUCTURE INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF POLIOVIRUS COMPONENTS.

Authors:  S PENMAN; Y BECKER; J E DARNELL
Journal:  J Mol Biol       Date:  1964-04       Impact factor: 5.469

2.  SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES.

Authors:  I TAMM; H J EGGERS
Journal:  Science       Date:  1963-10-04       Impact factor: 47.728

3.  Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production.

Authors:  D BALTIMORE; H J EGGERS; R M FRANKLIN; I TAMM
Journal:  Proc Natl Acad Sci U S A       Date:  1963-06       Impact factor: 11.205

4.  In vitro guanidino-resistance and guanidino-dependence of poliovirus.

Authors:  B LODDO; W FERRARI; A SPANEDDA; G BROTZU
Journal:  Experientia       Date:  1962-11-15

5.  Poliovirus coat protein as the site of guanidine action.

Authors:  B D Korant
Journal:  Virology       Date:  1977-08       Impact factor: 3.616

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Membrane leakiness after viral infection and a new approach to the development of antiviral agents.

Authors:  L Carrasco
Journal:  Nature       Date:  1978-04-20       Impact factor: 49.962

8.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

9.  Cell killing by simian virus 40: impairment of membrane formation and function.

Authors:  L C Norkin
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

10.  Antiviral effect of guanidine.

Authors:  W A RIGHTSEL; J R DICE; R J McALPINE; E A TIMM; I W McLEAN; G J DIXON; F M SCHABEL
Journal:  Science       Date:  1961-08-25       Impact factor: 47.728

View more
  6 in total

1.  Monovalent cation metabolism and cytopathic effects of poliovirus-infected HeLa cells.

Authors:  C N Nair
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

2.  Reversion by hypotonic medium of the shutoff of protein synthesis induced by encephalomyocarditis virus.

Authors:  M A Alonso; L Carrasco
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

3.  Myxoviruses do not induce non-specific alterations in membrane permeability early on in infection.

Authors:  K A Foster; K J Micklem; G Agnarsdottir; C L Lancashire; N N Bogomolova; Y S Boriskin; C A Pasternak
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Poliovirus-induced alterations in HeLa cell membrane functions.

Authors:  A Schaefer; J Kühne; R Zibirre; G Koch
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

Review 5.  Regulation of protein synthesis in virus-infected animal cells.

Authors:  M Kozak
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

Review 6.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.